Viewing Study NCT04723394


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-22 @ 6:57 PM
Study NCT ID: NCT04723394
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2021-01-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment of COVID-19 View